Search details
1.
A spatial portrait of the human sebaceous gland transcriptional program.
J Biol Chem
; : 107442, 2024 Jun 03.
Article
in English
| MEDLINE | ID: mdl-38838779
2.
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
Lancet
; 2024 May 22.
Article
in English
| MEDLINE | ID: mdl-38795716
3.
Exosomes from adipose-derived stem cells activate sebocytes through the PI3K/AKT/SREBP-1 pathway to accelerate wound healing.
Cell Tissue Res
; 396(3): 329-342, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38411945
4.
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled clinical trial.
Br J Dermatol
; 2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38576350
5.
Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials.
Br J Dermatol
; 190(6): 836-845, 2024 May 17.
Article
in English
| MEDLINE | ID: mdl-38470171
6.
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study.
J Am Acad Dermatol
; 90(3): 521-529, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37871805
7.
The Global Hidradenitis Suppurativa Atlas (GHiSA) Methodology: Combining Global Proportions in a Pooled Analysis.
Dermatology
; 2024 Feb 14.
Article
in English
| MEDLINE | ID: mdl-38354718
8.
Isotretinoin-associated acne fulminans: A multicentre, retrospective study of the European Academy of Dermatology and Venereology Task Force on Acne, Rosacea and Hidradenitis Suppurativa.
J Eur Acad Dermatol Venereol
; 38(1): 197-204, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37643921
9.
Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients.
J Eur Acad Dermatol Venereol
; 2024 Apr 10.
Article
in English
| MEDLINE | ID: mdl-38595320
10.
Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients.
J Eur Acad Dermatol Venereol
; 38(4): 741-751, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38168748
11.
Interleukins 4 and 13 drive lipid abnormalities in skin cells through regulation of sex steroid hormone synthesis.
Proc Natl Acad Sci U S A
; 118(38)2021 09 21.
Article
in English
| MEDLINE | ID: mdl-34521750
12.
S2k guideline for the treatment of hidradenitis suppurativa / acne inversa - Short version.
J Dtsch Dermatol Ges
; 2024 May 21.
Article
in English
| MEDLINE | ID: mdl-38770982
13.
12th European Hidradenitis Suppurativa (EHSF) e.V. Conference-Facing HS according to the Renessaince style.
Exp Dermatol
; 32 Suppl 1: 3-8, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37759367
14.
Desaturation of sebaceous-type saturated fatty acids through the SCD1 and the FADS2 pathways impacts lipid neosynthesis and inflammatory response in sebocytes in culture.
Exp Dermatol
; 32(6): 808-821, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36843338
15.
Preservation of epidermal melanocyte integrity in an ex vivo co-culture skin model with sebocytes.
Exp Dermatol
; 32(7): 1063-1071, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37287089
16.
Chronic Inflammatory Intestinal Disorders in Hidradenitis Suppurativa.
Dermatology
; 239(4): 592-600, 2023.
Article
in English
| MEDLINE | ID: mdl-37019083
17.
Viewpoint on the evaluation of severity and treatment effects in mild hidradenitis suppurativa: the cumulative IHS4 (IHS4-C).
Dermatology
; 2023 Dec 20.
Article
in English
| MEDLINE | ID: mdl-38118429
18.
Which Health-Related Quality of Life Items Most Affect Acne Patients?
Dermatology
; 239(2): 267-272, 2023.
Article
in English
| MEDLINE | ID: mdl-36476839
19.
External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort.
Dermatology
; 239(3): 362-367, 2023.
Article
in English
| MEDLINE | ID: mdl-36630943
20.
Measuring Quality of Life in Hidradenitis Suppurativa: Development and Validation of a Disease-specific Patient-reported Outcome Measure for Practice and Research.
Acta Derm Venereol
; 103: adv00859, 2023 Jan 31.
Article
in English
| MEDLINE | ID: mdl-36129249